Paperpal Prime Logo

Neurodegenerative Disease Management : Impact Factor & More

eISSN: 1758-2032pISSN: 1758-2024

Key Metrics

CiteScore
3.6
H-Index
29
SJR
Q2Neurology (clinical)
SNIP
0.59
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurodegenerative Disease Management

Neurodegenerative Disease Management Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Neurodegenerative Disease Management ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurodegenerative Disease Management

Mapping care interventions for people living with motor neurone disease: a living evidence and gap map.
  • 18 Oct 2026
  • Neurodegenerative disease management
Dual targeting of melatonergic and serotonergic neurotransmissions in Parkinson’s disease: role of agomelatine
  • 8 Oct 2026
  • Neurodegenerative Disease Management
Aqueous extracts of <i>Phyllanthus amarus</i> leaf mitigate cognitive impairments by enhancing neurotransmitter regulation and antioxidant defense mechanisms
  • 8 Oct 2026
  • Neurodegenerative Disease Management
Molecular and genetic basis of alzheimer's disease and emerging treatment Modalities.
  • 2 Oct 2026
  • Neurodegenerative disease management
Trends in mortality of Alzheimer's disease with comorbid hypertension in patients in the US from 1999-2020.
  • 30 Sep 2026
  • Neurodegenerative disease management
Estrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington's disease.
  • 29 Sep 2026
  • Neurodegenerative disease management
Mapping care interventions for people living with motor neurone disease: a living evidence and gap map.
  • 18 Oct 2026
  • Neurodegenerative disease management
Dual targeting of melatonergic and serotonergic neurotransmissions in Parkinson’s disease: role of agomelatine
  • 8 Oct 2026
  • Neurodegenerative Disease Management
Aqueous extracts of <i>Phyllanthus amarus</i> leaf mitigate cognitive impairments by enhancing neurotransmitter regulation and antioxidant defense mechanisms
  • 8 Oct 2026
  • Neurodegenerative Disease Management
Molecular and genetic basis of alzheimer's disease and emerging treatment Modalities.
  • 2 Oct 2026
  • Neurodegenerative disease management
Trends in mortality of Alzheimer's disease with comorbid hypertension in patients in the US from 1999-2020.
  • 30 Sep 2026
  • Neurodegenerative disease management
Estrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington's disease.
  • 29 Sep 2026
  • Neurodegenerative disease management

FAQs on Neurodegenerative Disease Management